Aurelius Health Group Review
Tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: starting below a standard dose, with microdose tiers
Aurelius Health Group falls below our bar on medical oversight. Read the breakdown below before you give it money.
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Month one costs $89; every month after that is $199, a figure taking in consultations, the protocol itself, shipping and monitoring. Rather than standard full-dose therapy, the whole platform is built on microdosed compounded tirzepatide, a dual GIP/GLP-1 approach given at low dose. Add-ons are optional: NAD+, L-carnitine, B12, inositol. Worth noting, the site does not hide that trial data behind microdosing is thin.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to Aurelius Health Group
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Aurelius Health Group at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Tirzepatide
- Starting price
- $89/mo
- What's included
- Medication · Consult
- FDA status
- No FDA warning letter on record
How Aurelius Health Group scores
Six columns, each one computed from something Aurelius Health Group has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
7.1/10$199/month is 25% below the register median of $267 for compounded tirzepatide.
Effectiveness25%
10.0/10Dispenses tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
5.5/10does not name a dispensing pharmacy; shows a price before asking for health information. Our verification confidence is low.
Accessibility10%
5.0/10Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
Support10%
5.5/10The price covers medication, consult.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Aurelius Health Group
Last checked August 2026- Re-read the price on file across 2 dose or plan tiers
- Established what the monthly figure covers, and what it leaves out
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: low.
What signing up with Aurelius Health Group involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1Aurelius Health Group publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3Aurelius Health Group does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- 4The monthly price is recorded as covering medication, consult.
- Cheapest standing monthly prices on record: tirzepatide $199. Membership fees, first-month rates and insured copays are excluded from those figures.
- No state list is published, so whether Aurelius Health Group serves your state cannot be confirmed from its site.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Aurelius Health Group support, as documented
- Phone
- (415) 354-6875
GLP-1 medications Aurelius Health Group offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Peptides Aurelius Health Group offers
Aurelius Health Group sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off Aurelius Health Group's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide at $199 a month, within the normal band around this register's $267 median for the same drug and form
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication and consult
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its tirzepatide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Aurelius Health Group charges
The standing price at Aurelius Health Group is $89/month. That sits at the affordable end of what we track.
- Compounded tirzepatide — $89/month
- Compounded tirzepatide — $199/month
Across the GLP-1 providers in our register the median standing price is about $169/month, so Aurelius Health Group is genuinely under the middle rather than merely advertising that it is.
Ozari Health dispenses tirzepatide from $86/month, which makes it the honest comparison to run before committing here.
What Aurelius Health Group dispenses
Aurelius Health Group prescribes tirzepatide (approved as Zepbound and Mounjaro). Between them these are one of the most heavily studied molecules in this class. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product — the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
What we could verify
Aurelius Health Group publishes little that can be checked from outside an intake. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- the lowest standing monthly cost is what you are solving for
Our read
Aurelius Health Group competes on price and does it without an obvious sacrifice elsewhere: $89/month, no warning letter on file, and access that is not unusually restricted.
The Bottom Line
Aurelius Health Group falls below our bar on medical oversight. Read the breakdown below before you give it money.
Before you pay Aurelius Health Group
Starting at $89/month. Check today's price, then book the free consultation.
Where Aurelius Health Group is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Aurelius Health Group review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 7.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See Aurelius Health Group's current pricing
Plans start at $89/month. The free consultation is where you learn whether you qualify, and what it costs today.